Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy and comparison with alternative tests: individual patient data meta-analysis

摘要

BackgroundMagnetic resonance imaging (MRI) may guide breast cancer surgery by measuring residual tumor size post-neoadjuvant chemotherapy (NAC). Accurate measurement may avoid overly radical surgery or reduce the need for repeat surgery. This individual patient data (IPD) meta-analysis examines MRI’s agreement with pathology in measuring the longest tumor diameter and compares MRI with alternative tests.